Podiapn (pyridoxal phos/methyltetrahydrofolate gluc/mecobalamin/ala) — PHARMCEUTIX

35 mg-5 mg-2 mg-300 mg capsule
Dosage information is not available

Severe Warnings
None
Contraindicated
Gastrectomy
Leber's hereditary optic atrophy
Moderate Warnings
Atrophic gastritis
Hypokalemia
No disease contraindications
Less Frequent
Severe
None

Less Severe
Diarrhea
Pruritus of skin
More Frequent
Severe
None

Less Severe
None
Rare / Very Rare
Severe
None

Less Severe
None
More information
No precaution information has been provided for this patient type.
No precaution information has been provided for this patient type.
More information
Contraindicated
None

Precaution Exists
Thioctic Acid
GeneralExcretion PotentialEffect on InfantNotes
Evaluate use carefullyUnknownNot known; no or inclusive dataInsufficient data available.

No Known Risk
Mecobalamin
GeneralExcretion PotentialEffect on InfantNotes
No known risks; does not adversely affect lactationUnknownNot known; no or inclusive dataCyanocobalamin, related to mecobalamin, is excreted with no infant adrs
More information
No precaution information has been provided for this patient type.
No ICD codes found for this drug.

Data included with permission and copyrighted by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgement of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. Diagnosis codes are provided for reference only. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatement.